About

Savanna Stromberg, BS, is an associate project coordinator at Stanford CDI, who works across projects on C-DIAS, CMHIS, and RASC. Savanna recently received her BS in Psychology from the University of Washington, where she conducted research on trauma and mental health outcomes in the Honors Psychology program. With a strong interest in substance use interventions…

Elena Rosenberg-Carlson, MPH, is a Research Scientist and Project Director for the Stagewise Implementation to Target – Medications for Addiction Treatment (SITT-MAT) study at Stanford CDI. She has significant experience managing and supporting implementation research and capacity-building initiatives in collaboration with academic, public health, and community partners, most recently as part of the UCLA Center…

Dr. Vroom is an assistant professor in the Department of Medicine at s The University of Texas at San Antonio. She is also a Core Scholar at the Center for Research to Advance Community Health and faculty at the Be Well Institute for Substance Use & Related Disorders. Dr. Vroom earned a PhD in Behavioral…

Dr. Smith is an assistant professor at Washington State University in the Elson S. Floyd College of Medicine Department of Community and Behavioral Health and the Human Development Prevention Science program. For over a decade, she has been actively engaged with the Program for Excellence in Addictions Research, and she recently established the Laboratory for…

Dr. Messmer is an assistant professor at the University of Illinois Chicago (UIC) and is board-certified in internal medicine, pediatrics, and addiction medicine. Dr. Messmer is the clinical lead of the UIC Community Outreach Intervention Projects (COIP) Mobile Medications for Opioid Use Disorder program, which provides low-barrier substance use treatment and primary care via mobile…

Dr. Ludwig-Barron is a Chicana/Mexican-American epidemiologist and assistant professor at the University of California, San Francisco (UCSF), Department of Medicine, Division of Prevention Science. She brings more than 15-years of public health research and practice experience applying mixed methods and ecological approaches to understanding the co-occurring epidemics of HIV/AIDS, hepatitis C, substance use, and gender…

Dr. Levander (She/Her/Ella) is an assistant professor of medicine and an addiction medicine clinician researcher at Oregon Health & Science University (OHSU) in Portland, Oregon. She is inspired by her clinical work in both inpatient and outpatient settings to improve care for and reduce harms related to substance use amongst women who use drugs, particularly…

Dr. Garneau is an assistant professor of medicine and hospitalist at Johns Hopkins Hospital. His work is focused on improving care for hospitalized patients with substance use disorders, particularly managing opioid dependence and prompt treatment of withdrawal to reduce patient-directed discharges. He received an NIH KL2 mentored career development award in 2023 and uses real-world…

Dr. French is an assistant professor in the Department of Family and Community Health at Penn Nursing. With a background as a registered nurse in a federally qualified health center providing opioid use disorder treatment, Dr. French witnessed firsthand how community-based care for opioid use disorder is often disrupted when patients are hospitalized. This experience…

Hannah Begna, MS, is a research data analyst at C-DIAS. Hannah has dedicated her career to advancing public health and academic research, with experience spanning communicable diseases, HIV, women’s health, and mental health. She holds a bachelor’s degree in kinesiology from the University of Western Ontario and a master’s in global health sciences from the…